Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (1500)	3/6/1998 12:57:00 AM
From: Ryan Weisman	Read Replies (1) \| Respond to of 1894

My pop analysis is that the cyto division is growing in triple digits, while the molecular was at a more sustained rate. Sales growth on the cyto side can be focused on with all resources. Great analysis of ACMIC's battle with Neo...I see international opportunity for Accumed to forge ahead in nations where this technology has yet to be introduced/assimilated. Are we talking about astronomincal growth in the coming years, as the debt-free engines begin to churn? Like the news, like the plan, like the fact that things are happening in this story, RYAN